ESC 365 - Dispelling the myth: are HFrEF patients ever 'stable'?

Open Access

Dispelling the myth: are HFrEF patients ever 'stable'?

Session: Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor M. Cikes (Zagreb, HR)

Sponsored by Bayer AG

Event: Heart Failure 2025

Congress Presentation

Sign in to view the resources

Add to my library

Page viewed 61 times

About the speaker

Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)

75 presentations

27 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor J. Butler (Dallas, US)

Optimising treatment for high-risk patients: lessons from VICTORIA

Speaker: Professor S. Greene (Durham, US)

Enhancing the approach to titration: the VELOCITY trial

Speaker: Professor M. Senni (Bergamo, IT)

Advancing therapeutic options in HFrEF: the VICTOR trial

Speaker: Professor J. Butler (Dallas, US)

Expert panel discussion and Q&A

Access the full session

Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Speakers: Professor M. Cikes, Professor J. Butler, Professor S. Greene, Professor M. Senni, Professor J. Butler

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress